bioMerieux

GHX Announces 2008 Best In Class Award Winners

...ly/Sci Products** Metal/Plastic/Paper Products Care Line Inc. Microbiology Reagents/Supplies biomerieux SA Needles & Syringes NovoNordisk Ostomy Coloplast** Parenteral B Brau...

bioMerieux in Medical Technology

Data From Clinical Study of bioTheranostics Molecular Diagnostic Test Presented at American Society of Clinical Oncology Annual Meeting

...cent accuracy in patients whose primary cancer was 'unknown' using traditional diagnostics - SAN DIEGO, June 1 /PRNewswire/ -- bioTheranostics, a biomerieux company that discovers, develops and commercializes new molecular diagnostic tests in oncology, announced that a recent study demonstrated the company...

ExonHit Reports Proof-of-Concept in Breast Cancer Diagnostic Using its SpliceArray(TM) Platform

...'s disease and cancers. ExonHit has a balanced investment strategy with internal development programs and strategic collaborations, in particular with biomerieux and Allergan. ExonHit is headquartered in Paris, France and has a U.S. facility in Gaithersburg, Maryland. The Company is listed on Alternext o...

Foreign Medical Devices are in High Demand in Russia

...Zeneca - Boehringer Ingelheim - GlaxoSmithKline - Novartis - Dade Behring - Ortho-Clinical Diagnostics - Beckman Coulter - biomerieux Sa - St. Jude Medical - Sorin - Biotronik - Kazanskiy Zavod Meditsinskoy - Kazanskiy Mediko-Instrumentalniy - Uralsky Priboros...

Three Clinical Studies of bioTheranostics Molecular Breast Cancer Diagnostics Presented at San Antonio Breast Cancer Symposium

... DIEGO, Dec. 14 /PRNewswire/ -- bioTheranostics, a biomerieux company that discovers, develops and commercialize...llion with 84% of sales outside of France. biomerieux provides diagnostic solutions (reagents, instrumen...n agri-food, pharmaceutical and cosmetic products. biomerieux is listed on the NYSE Euronext Paris market (Code:...

ExonHit's EHT 0202 Counters Scopolamine's Detrimental Effects on Cognition in Humans

... These products are marketed worldwide in conjunction with Agilent and Affymetrix. In the field of diagnostics, ExonHit has a major collaboration with biomerieux to develop completely novel predictive blood-based cancer diagnostics, which could play a key role in improving the treatment of breast cancer and oth...

bioMerieux in Biological News

Affymetrix and bioMerieux Extend Their Agreement on GeneChip(R) Technology to Breast Cancer Diagnostics

Affymetrix Inc. (Nasdaq: AFFX) and bioMerieux announced today that Affymetrix has granted bioMerieux long-term and comprehensive access to its GeneChip(R) technology to develop and market in vitro diagnostic tests for breast cancer, as well as an option to expand the agreement into other cancer are...

bioMerieux in Biological Technology

Laboratory Customers Name bioMerieux 'Top Of Class' for Microbiology

DURHAM, N.C., Dec. 17 /PRNewswire/ -- In a recent customer satisfaction survey of over 30,000 readers of ADVANCE for Administrators of the Laboratory, bioMerieux was voted by its customers as the "Top Of Class" winner for the microbiology category. The top-level lab managers and pathologists who s...

ExonHit and bioMerieux Amend Their Strategic Partnership

PARIS, January 9 /PRNewswire-FirstCall/ -- ExonHit Therapeutics, a drug and diagnostic discovery company, announced today that it has signed an amendment to its strategic partnership with bioMerieux in the field of cancer diagnostics. Under the terms of the amendment, ExonHit will gain commerc...

The Institut Pasteur and Merieux Alliance Take First Step Towards a Long-Term Research Partnership in the Field of Infectious Diseases

... - Clinical diagnostics and theranostics (in partnership with biomerieux and Transgene) - Food safety and microbiological control, nutrition, health and environment (with biomerieux and Silliker) - Immunotherapy (with Transgene and Shantha Biotechnics)...

ExonHit Therapeutics Invested Strongly in 2008 for Pivotal 2009 Results

...t in the clinical trial market in Q4 2009, and in the clinical diagnostic market in a second step through a partnering model. In February 2009, biomerieux and ExonHit Therapeutics agreed on new research and development plans as part of their existing collaboration to develop blood-based cancer detection ...

bioMerieux Introduces Surveillance Tool to Fight Healthcare-Associated Infections

...ard, executive vice president and general manager, biomerieux North America. "ICNet Systems, Inc. offers our cus... found at http://www.icnetplc.com . About biomerieux Advancing Diagnostics to Improve Public Hea...illion with 84% of sales outside of France. biomerieux provides diagnostic solutions (reagents, instrumen...

ExonHit is Honoured by the "Innovation Trophy" From The National Institute of Industrial Property (INPI)

... These products are marketed worldwide in conjunction with Agilent and Affymetrix. In the field of diagnostics, ExonHit has a major collaboration with biomerieux to develop completely novel predictive blood-based cancer diagnostics, which could play a key role in improving the treatment of breast cancer and oth...

ExonHit Launches Mouse Genome SpliceArray(TM) for use in Human Disease Modeling Studies

... These products are marketed worldwide in conjunction with Agilent and Affymetrix. In the field of diagnostics, ExonHit has a major collaboration with biomerieux to develop completely novel predictive blood-based cancer diagnostics, which could play a key role in improving the treatment of breast cancer and oth...

World Market for Biotechnology Reagents to Reach $32.5 Billion by 2012, According to New Report by Global Industry Analysts, Inc.

...gents. Key players dominating the marketplace include Abbott Diagnostics, Applied Biosystems, Beckman Coulter Inc., Becton Dickinson and Company, biomerieux SA, Chemicon International Inc., Cortex Biochem Inc., EMD Biosciences Inc., GE Healthcare, Invitrogen Corporation, Ortho-Clinical Diagnostics, PerkinE...

Global Agricultural and Environmental Diagnostics Market to Reach $2.4 Billion by 2012, According to New Report by Global Industry Analysts

...15 provide a comprehensive understanding of the market. Dominant global forces profiled in the report include Agdia Inc., Biocontrol Systems Inc., biomerieux SA, Biotrace International Plc., Charm Sciences, C-Qentec Diagnostics, Eurofins Scientific, IDEXX Laboratories, Inc., Neogen Corporation, R-Biopharm, ...

U.S. Clinicians Indicate a Strong Need for New Tools to Combat Sepsis

...ntibiotics DURHAM, N.C., July 24 /PRNewswire/ -- biomerieux recently conducted two surveys, fielded during con...lion with 84 percent of sales outside of France. biomerieux provides diagnostic solutions (reagents, instrumen... agri-food, pharmaceutical, and cosmetic products. biomerieux is listed on the NYSE Euronext Paris market (Code:...